4 - ABBREVIATED MRI PROTOCOL TO EVALUATE RESPONSE TO BREAST CANCER NEOADJUVANT CHEMOTHERAPY

Autores

  • Eduardo Carnier Dornelas Pontifícia Universidade Católica do Paraná – Curitiba (PR), Brazil.
  • Linei Augusta Brolini Dellê Urban Diagnóstico Avançado por Imagem – Curitiba (PR), Brazil.
  • Carolina de Lima Bolzon Universidade Federal do Paraná – Curitiba (PR), Brazil.
  • Iris Rabinovich Universidade Federal do Paraná – Curitiba (PR), Brazil.
  • Selene Elifio Esposito Pontifícia Universidade Católica do Paraná – Curitiba (PR), Brazil.

DOI:

https://doi.org/10.29289/259453942022V32S1002

Resumo

Introduction: Abbreviated MRI protocols have been proposed to reduce examination time, patient discomfort, and costs
for breast cancer screening. However, an abbreviated MRI protocol for assessing neoadjuvant chemotherapy in breast cancer is yet to be explored. Objective: We sought to develop an abbreviated MRI protocol to evaluate the response to neoadjuvant chemotherapy treatment for invasive breast cancer carcinoma with diagnostic performance equivalent to that of
the full protocol. Methods: This was a retrospective, single-center, cross-sectional study. This study comprised 210 women
diagnosed with invasive breast carcinoma of no special type who underwent breast MRI after neoadjuvant chemotherapy
between 2016 and 2020 in Curitiba, PR, Brazil. Breast MRI scans were reevaluated, first with access only to axial 3D SPAIR
without contrast and first post-contrast time (two sequences); next to the second post-contrast time (three sequences);
then to the third post-contrast time (four sequences); and finally, to the full protocol (seven sequences). The diagnostic
performance (sensitivity, specificity, positive predictive value, negative predictive value, and accuracy) of the three abbreviated protocols and the full protocol was analyzed using the Wilcoxon nonparametric test. Results: The median age of
the study population was 47 years. The diagnostic performance of abbreviated protocols with three and four sequences
and the full protocol was identical. The two-sequence abbreviated protocol showed higher specificity (84.6%), but a higher
probability of false negatives (16.8%) and a lower sensitivity (83.2%) than the other protocols, which showed values of 81.3,
8.4, and 91.6%, respectively. The abbreviated protocol with three sequences showed an average underestimation of only
0.03 cm in the measurement of the longest axis of the residual lesion (p=0.008), but an average reduction in acquisition
time of 75%. Conclusion: The three-sequence abbreviated MRI protocol showed diagnostic performance equivalent to
the full protocol but with a 75% reduction in acquisition time.

Downloads

Não há dados estatísticos.

Downloads

Publicado

2026-03-23

Como Citar

Dornelas, E. C., Urban, L. A. B. D., Bolzon, C. de L., Rabinovich, I., & Esposito, S. E. (2026). 4 - ABBREVIATED MRI PROTOCOL TO EVALUATE RESPONSE TO BREAST CANCER NEOADJUVANT CHEMOTHERAPY. Mastology, 32(suppl.1). https://doi.org/10.29289/259453942022V32S1002

Edição

Seção

Abstract